Numazu, Japan

Hiroyuki Harakawa

This inventor holds 2 USPTO granted patents. Top assignee: Kyowa Hakko Kogyo Co., Ltd.. Active years: 1994-1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hiroyuki Harakawa. Retrieved from https://idiyas.com/inventor/hiroyuki-harakawa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 2

Forward Citations = 19(Granted Patents)


Company Filing History:


Years Active: 1994-1995

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Hiroyuki Harakawa: Innovator in Tricyclic Compounds

Introduction

Hiroyuki Harakawa is a notable inventor based in Numazu, Japan. He has made significant contributions to the field of chemistry, particularly in the development of tricyclic compounds. With a total of 2 patents to his name, Harakawa's work is recognized for its potential therapeutic applications.

Latest Patents

Harakawa's latest patents focus on tricyclic compounds and their intermediates. These compounds are represented by complex chemical formulas, where various groups can be substituted to create different derivatives. The compounds exhibit acyl coenzyme A: cholesterol acyltransferase-inhibiting activity, which suggests they may have preventive and therapeutic effects on conditions such as hyperlipemia and arteriosclerosis.

Career Highlights

Hiroyuki Harakawa is associated with Kyowa Hakko Kogyo Co., Ltd., a company known for its innovative approaches in biotechnology and pharmaceuticals. His work has contributed to advancements in medicinal chemistry, particularly in the synthesis of compounds that could lead to new treatments for cardiovascular diseases.

Collaborations

Harakawa has collaborated with notable coworkers, including Toshiaki Kumazawa and Masashi Yanase. These collaborations have likely enhanced the research and development of the compounds he has patented.

Conclusion

Hiroyuki Harakawa's contributions to the field of tricyclic compounds highlight his role as an innovator in medicinal chemistry. His work continues to pave the way for potential advancements in therapeutic treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…